| Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing J Grzegorzewski, F Bartsch, A Köller, M König Frontiers in pharmacology 12, 752826, 2022 | 72 | 2022 |
| PK-DB: pharmacokinetics database for individualized and stratified computational modeling J Grzegorzewski, J Brandhorst, K Green, D Eleftheriadou, Y Duport, ... Nucleic acids research 49 (D1), D1358-D1364, 2021 | 43 | 2021 |
| Prediction of survival after partial hepatectomy using a physiologically based pharmacokinetic model of indocyanine green liver function tests A Köller, J Grzegorzewski, HM Tautenhahn, M König Frontiers in physiology 12, 730418, 2021 | 18 | 2021 |
| Physiologically based modeling of the effect of physiological and anthropometric variability on indocyanine green based liver function tests A Köller, J Grzegorzewski, M König Frontiers in physiology 12, 757293, 2021 | 9 | 2021 |
| Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4 M Albadry, J Küttner, J Grzegorzewski, O Dirsch, E Kindler, R Klopfleisch, ... Frontiers in Pharmacology 15, 1404938, 2024 | 6 | 2024 |
| Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan J Grzegorzewski, J Brandhorst, M König Frontiers in Pharmacology 13, 1029073, 2022 | 6 | 2022 |
| Multi-modal Transfer Learning between Biological Foundation Models JJ Garau-Luis, P Bordes, L Gonzalez, M Roller, BP de Almeida, ... arXiv preprint arXiv:2406.14150, 2024 | 3 | 2024 |
| Ten Simple Rules for FAIR Sharing of Experimental and Clinical Data with the Modeling Community M König, J Grzegorzewski, M Golebiewski, H Hermjakob, M Hucka, ... Preprints, 2021 | 3 | 2021 |
| Ten simple rules for sharing experimental and clinical data with the modeling community M König, J Grzegorzewski, M Golebiewski, H Hermjakob, M Hucka, ... Preprints. doi 10, 2021 | 2 | 2021 |
| Insights into Intestinal P-glycoprotein Function using Talinolol: A PBPK Modeling Approach BS Mallol, J Grzegorzewski, HM Tautenhahn, M König bioRxiv, 2023.11. 21.568168, 2023 | 1 | 2023 |
| A physiologically based pharmacokinetic model for CYP2E1 phenotyping via chlorzoxazone J Küttner, J Grzegorzewski, HM Tautenhahn, M König bioRxiv, 2023.04. 12.536571, 2023 | 1 | 2023 |
| Dynamic flux balance analysis models in SBML M König, LH Watanabe, J Grzegorzewski, CJ Myers Preprint, Bioinformatics, January, 2018 | 1 | 2018 |
| Insights into Intestinal P-glycoprotein Function using Talinolol: A PBPK Modeling Approach J Grzegorzewski, M König | | 2023 |
| Simvastatin therapy in different subtypes of hypercholesterolemia–a physiologically based modelling approach F Bartsch, J Grzegorzewski, HL Pujol, HM Tautenhahn, M König medRxiv, 2023.02. 01.23285358, 2023 | | 2023 |
| Physiologically based pharmacokinetic (PBPK) modeling for dynamical liver function tests and CYP phenotyping J Grzgorzewski Humboldt-Universität zu Berlin, 2023 | | 2023 |
